[1]
|
Long, H.K., Blackledge, N.P. and Klose, R.J. (2013) ZF-CXXC Domain-Containing Proteins, CpG Islands and the Chromatin Connection. Biochemical Society Transactions, 41, 727-740. https://doi.org/10.1042/BST20130028
|
[2]
|
Ravasi, T., Huber, T., Zavolan, M., et al. (2003) Systematic Characterization of the Zinc-Finger-Containing Proteins in the Mouse Transcriptome. Genome Research, 13, 1430-1442. https://doi.org/10.1101/gr.949803
|
[3]
|
Pendino, F., Nguyen, E., Jonassen, I., et al. (2009) Functional Involvement of RINF, Retinoid-Inducible Nuclear Factor (CXXC5), in Normal and Tumoral Human Myelopoiesis. Blood, 113, 3172-3181.
https://doi.org/10.1182/blood-2008-07-170035
|
[4]
|
Rost, B., et al. (2000) Finding Nuclear Localization Signals. EMBO Journal, 1, 411-415.
https://doi.org/10.1093/embo-reports/kvd092
|
[5]
|
Kalderon, D., Roberts, B.L., Richardson, W.D., et al. (1984) A Short Amino Acid Sequence Able to Specify Nuclear Location. Cell, 39, 499-509. https://doi.org/10.1016/0092-8674(84)90457-4
|
[6]
|
Wang, X., Liao, P., Fan, X., et al. (2013) CXXC5 Associates with Smads to Mediate TNF-α Induced Apoptosis. Current Molecular Medicine, 13, 1385-1396. https://doi.org/10.2174/15665240113139990069
|
[7]
|
Tsuchiya, Y., Naito, T., Tenno, M., et al. (2016) ThPOK Represses CXXC5, Which Induces Methylation of Histone H3 Lysine 9 in Cd40lg Promoter by Association with SUV39H1: Implications in Repression of CD40L Expression in CD8+ Cytotoxic T Cells. Journal of Leukocyte Biology, 100, 327-338. https://doi.org/10.1189/jlb.1A0915-396RR
|
[8]
|
Long, F. (2012) Building Strong Bones: Molecular Regulation of the Osteoblast Lineage. Nature Reviews Molecular Cell Biology, 13, 27-38. https://doi.org/10.1038/nrm3254
|
[9]
|
Rachner, T.D., Khosla, S. and Hofbauer, L.C. (2011) Osteoporosis: Now and the Future. The Lancet, 377, 1276-1287.
https://doi.org/10.1016/S0140-6736(10)62349-5
|
[10]
|
Regard, J.B., Zhong, Z., Williams, B.O., et al. (2012) Wnt Signaling in Bone Development and Disease: Making Stronger Bone with Wnts. Cold Spring Harbor Perspectives in Biology, 4, 1-17.
https://doi.org/10.1101/cshperspect.a007997
|
[11]
|
Lee, I., Choi, S., Yun, J.H., et al. (2017) Crystal Structure of the PDZ Domain of Mouse Dishevelled 1 and Its Interaction with CXXC5. Biochemical and Biophysical Research Communications, 485, 584-590.
https://doi.org/10.1016/j.bbrc.2016.12.023
|
[12]
|
Kim, H.-Y., Yoon, J.-Y., Yun, J.-H., et al. (2015) CXXC5 Is a Negative-Feedback Regulator of the Wnt/β-Catenin Pathway Involved in Osteoblast Differentiation. Cell Death & Differentiation, 22, 912-920.
https://doi.org/10.1038/cdd.2014.238
|
[13]
|
Choi, S., Kim, H.Y., Cha, P.H., et al. (2019) CXXC5 Mediates Growth Plate Senescence and Is a Target for Enhancement of Longitudinal Bone Growth. Life Science Alliance, 2, e201800254. https://doi.org/10.26508/lsa.201800254
|
[14]
|
Ma, L., Wang, X., Liu, H., et al. (2019) CXXC5 Mediates P. gingivalis-Suppressed Cementoblast Functions Partially via MAPK Signaling Network. International Journal of Biological Sciences, 15, 1685-1695.
https://doi.org/10.7150/ijbs.35419
|
[15]
|
Kim, M.S., Yoon, S.K., Bollig, F., et al. (2010) A Novel Wilms Tumor 1 (WT1) Target Gene Negatively Regulates the WNT Signaling Pathway. Journal of Biological Chemistry, 285, 14585-14593.
https://doi.org/10.1074/jbc.M109.094334
|
[16]
|
Lee, S.H., Seo, S.H., Lee, D.H., et al. (2017) Targeting of CXXC5 by a Competing Peptide Stimulates Hair Re-Growth and Wound-Induced Hair Neogenesis. Journal of Investigative Dermatology, 137, 2260-2269.
https://doi.org/10.1016/j.jid.2017.04.038
|
[17]
|
Kim, M.Y., Kim, H.Y., Hong, J., et al. (2016) CXXC5 Plays a Role as a Transcription Activator for Myelin Genes on Oligodendrocyte Differentiation. Glia, 64, 350-362. https://doi.org/10.1002/glia.22932
|
[18]
|
PrithiRajan, D.M., et al. (2003) BMPs Signal Alternately through a SMAD or FRAP-STAT Pathway to Regulate Fate Choice in CNS Stem Cells. Journal of Cell Biology, 161, 911-921. https://doi.org/10.1083/jcb.200211021
|
[19]
|
Shimogori, T., Banuchi, V., Ng, H.Y., et al. (2004) Embryonic Signaling Centers Expressing BMP, WNT and FGF Proteins Interact to Pattern the Cerebral Cortex. Development, 131, 5639-5647. https://doi.org/10.1242/dev.01428
|
[20]
|
Hébert, J.M., Mishina, Y. and McConnell, S.K. (2002) BMP Signaling Is Required Locally to Pattern the Dorsal Telencephalic Midline. Neuron, 35, 1029-1041. https://doi.org/10.1016/S0896-6273(02)00900-5
|
[21]
|
Andersson, T., Södersten, E., Duckworth, J.K., et al. (2009) CXXC5 Is a Novel BMP4-Regulated Modulator of Wnt Signaling in Neural Stem Cells. Journal of Biological Chemistry, 284, 3672-3681.
https://doi.org/10.1074/jbc.M808119200
|
[22]
|
Pi, M. and Quarles, L.D. (2012) Multiligand Specificity and Wide Tissue Expression of GPRC6A Reveals New Endocrine Networks. Endocrinology, 153, 2062-2069. https://doi.org/10.1210/en.2011-2117
|
[23]
|
Lee, N.K., Sowa, H., Hinoi, E., et al. (2007) Endocrine Regulation of Energy Metabolism by the Skeleton. Cell, 130, 456-469. https://doi.org/10.1016/j.cell.2007.05.047
|
[24]
|
Kim, H.Y., Yang, D.H., Shin, S.W., et al. (2014) CXXC5 Is a Transcriptional Activator of Flk-1 and Mediates Bone Morphogenic Protein-Induced Endothelial Cell Differentiation and Vessel Formation. The FASEB Journal, 28, 615-626. https://doi.org/10.1096/fj.13-236216
|
[25]
|
Li, G., Ye, X., Peng, X., et al. (2014) CXXC5 Regulates Differentiation of C2C12 Myoblasts into Myocytes. Journal of Muscle Research and Cell Motility, 35, 259-265. https://doi.org/10.1007/s10974-014-9400-2
|
[26]
|
Peng, X., Li, G., Wang, Y., et al. (2016) CXXC5 Is Required for Cardiac Looping Relating to TGF β Signaling Pathway in Zebrafish. International Journal of Cardiology, 214, 246-253. https://doi.org/10.1016/j.ijcard.2016.03.201
|
[27]
|
Knappskog, S., Myklebust, L.M., Busch, C., et al. (2011) RINF (CXXC5) Is Overexpressed in Solid Tumors and Is an Unfavorable Prognostic Factor in Breast Cancer. Annals of Oncology, 22, 2208-2215.
https://doi.org/10.1093/annonc/mdq737
|
[28]
|
Fang, L., Wang, Y., Gao, Y., et al. (2018) Overexpression of CXXC5 Is a Strong Poor Prognostic Factor in ER+ Breast Cancer. Oncology Letters, 16, 395-401. https://doi.org/10.3892/ol.2018.8647
|
[29]
|
Yasar, P., Ayaz, G., Muyan, M., et al. (2016) Estradiol-Estrogen Receptor α Mediates the Expression of the CXXC5 Gene through the Estrogen Response Element-Dependent Signaling Pathway. Scientific Reports, 25, Article No. 37808. https://doi.org/10.1038/srep37808
|
[30]
|
Bruserud, Ø., Reikvam, H., Fredly, H., et al. (2015) Expression of the Potential Therapeutic Target CXXC5 in Primary Acute Myeloid Leukemia Cells—High Expression Is Associated with Adverse Prognosis as Well as Altered Intracellular Signaling and Transcriptional Regulation. Oncotarget, 6, 2794-2811. https://doi.org/10.18632/oncotarget.3056
|
[31]
|
Kuhnl, A., Valk, P.J., Sanders, M.A., et al. (2015) Downregulation of the Wnt Inhibitor CXXC5 Predicts a Better Prognosis in Acute Myeloid Leukemia. Blood, 125, 2985-2994. https://doi.org/10.1182/blood-2014-12-613703
|
[32]
|
Astori, A., Fredly, H., Aloysius, T.A., et al. (2013) CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) Is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia. Oncotarget, 4, 1438-1448.
https://doi.org/10.18632/oncotarget.1195
|
[33]
|
Ko, M., An, J., Bandukwala, H.S., et al. (2013) Modulation of TET2 Expression and 5-Methylcytosine Oxidation by the CXXC Domain Protein IDAX. Nature, 497, 122-126. https://doi.org/10.1038/nature12052
|
[34]
|
Ma, S., Wan, X., Deng, Z., et al. (2017) Epigenetic Regulator CXXC5 Recruits DNA Demethylase Tet2 to Regulate TLR7/9-Elicited IFN Response in pDCs. Journal of Experimental Medicine, 214, 1471-1491.
https://doi.org/10.1084/jem.20161149
|
[35]
|
Kojima, T., Shimazui, T., Hinotsu, S., et al. (2009) Decreased Expression of CXXC4 Promotes a Malignant Phenotype in Renal Cell Carcinoma by Activating Wntsignaling. Oncogene, 28, 297-305. https://doi.org/10.1038/onc.2008.391
|
[36]
|
Reyes, I., Tiwari, R., Geliebter, J., et al. (2007) DNA Microarray Analysis Reveals Metastasis-Associated Genes in Rat Prostate Cancer Cell Lines. Biomedica, 27, 190-203. https://doi.org/10.7705/biomedica.v27i2.215
|
[37]
|
Bettin, A., Reyes, I., Reyes, N., et al. (2016) Gene Expression Profiling of Prostate Cancer-Associated Genes Identifies Fibromodulin as Potential Novel Biomarker for Prostate Cancer. The International Journal of Biological Markers, 31, e153-e162. https://doi.org/10.5301/jbm.5000184
|
[38]
|
Benedetti, I., DeMarzo, A.M., Geliebter, J., et al. (2017) CXXC5 Expression in Prostate Cancer: Implications for Cancer Progression. International Journal of Experimental Pathology, 98, 234-243. https://doi.org/10.1111/iep.12241
|
[39]
|
Liu, Y.T., Zong, D., Jiang, X.S., et al. (2019) miR-32 Promotes Esophageal Squamous Cell Carcinoma Metastasis by Targeting CXXC5. Journal of Cellular Biochemistry, 120, 6250-6263. https://doi.org/10.1002/jcb.27912
|
[40]
|
Tan, S., Li, H., Zhang, W., et al. (2018) NUDT21 Negatively Regulates PSMB2 and CXXC5 by Alternative Polyadenylation and Contributes to Hepatocellular Carcinoma Suppression. Oncogene, 37, 4887-4900.
https://doi.org/10.1038/s41388-018-0280-6
|
[41]
|
Ni, L.C., Kuang, Z.H., Gong, Z., et al. (2019) Dihydroartemisinin Promotes the Osteogenesis of Human Mesenchymal Stem Cells via the ERK and Wnt/β-Catenin Signaling Pathways. BioMed Research International, 2019, Article ID: 3456719. https://doi.org/10.1155/2019/3456719
|
[42]
|
陈世海, 谢兴文, 李建国, 等. Wnt/β-catenin信号通路在补肾中药靶向治疗骨质疏松症中应用的研究进展[J]. 中国骨质疏松杂志, 2019, 25(4): 559-563.
|